Skip to main navigation
Loading
  • News
  • Investors
  • Careers
  • Contact
  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
    • What We Do
    • Partnering
  • Patients & Caregiver
    • Clinical Trials
    • Expanded Access Policy
    • Niemann-Pick Disease Type C
    • Urea Cycle Disorders
    • Vascular Ehlers-Danlos
  • Our Products
    • MIPLYFFA®
    • OLPRUVA ®
  • Our Pipeline
    • Pipeline
    • Clinical Trials
    • Publications & Presentations
    • Medical Literature
    • Medical Information
    • Investigator-Initiated Studies
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Quote & Chart
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home
  • Menu Menu

SEC Filings

  • Overview
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Analyst Coverage
  • Press Releases
  • Corporate Governance
    • Leadership
    • Board of Directors
    • Committee Composition
    • IRS – Required Disclosures
  • State Compliance
  • SEC Filings
  • Contact
  • Email Alerts
  • FAQs
Filing date Form Description Filing Group View
02-04-2026 4 Statement of changes in beneficial ownership of securities
3,4,5
0001945557-26-000004.rtf
0001945557-26-000004.xls
0001945557-26-000004.pdf
View HTML
02-04-2026 4 Statement of changes in beneficial ownership of securities
3,4,5
0001698328-26-000004.rtf
0001698328-26-000004.xls
0001698328-26-000004.pdf
View HTML
02-02-2026 144 Filed by "insiders" prior intended sale of restricted stock.
Other
0001950047-26-000828.rtf
0001950047-26-000828.pdf
View HTML
02-02-2026 4 Statement of changes in beneficial ownership of securities
3,4,5
0001910132-26-000002.rtf
0001910132-26-000002.xls
0001910132-26-000002.pdf
View HTML
02-02-2026 4 Statement of changes in beneficial ownership of securities
3,4,5
0001945557-26-000002.rtf
0001945557-26-000002.xls
0001945557-26-000002.pdf
View HTML
02-02-2026 4 Statement of changes in beneficial ownership of securities
3,4,5
0001788524-26-000002.rtf
0001788524-26-000002.xls
0001788524-26-000002.pdf
View HTML
02-02-2026 4 Statement of changes in beneficial ownership of securities
3,4,5
0001681098-26-000002.rtf
0001681098-26-000002.xls
0001681098-26-000002.pdf
View HTML
02-02-2026 4 Statement of changes in beneficial ownership of securities
3,4,5
0001698328-26-000002.rtf
0001698328-26-000002.xls
0001698328-26-000002.pdf
View HTML
01-30-2026 144 Filed by "insiders" prior intended sale of restricted stock.
Other
0001950047-26-000769.rtf
0001950047-26-000769.pdf
View HTML
01-30-2026 144 Filed by "insiders" prior intended sale of restricted stock.
Other
0001950047-26-000773.rtf
0001950047-26-000773.pdf
View HTML
Pagination
  • First page «
  • Previous page ‹
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • …
  • Next page ›
  • Last page »

Data provided by Kaleidoscope.

  • About Us
    • Our Mission & Vision
    • The Zevra Story
    • Leadership
    • Board of Directors
    • What We Do
    • Partnering
  • Patients & Caregiver
    • Clinical Trials
    • Expanded Access Policy
    • Niemann-Pick Disease Type C
    • Urea Cycle Disorders
    • Vascular Ehlers-Danlos
  • Our Products
    • MIPLYFFA®
    • OLPRUVA ®
  • Our Pipeline
    • Pipeline
    • Clinical Trials
    • Publications & Presentations
    • Medical Literature
    • Medical Information
    • Investigator-Initiated Studies
  • Investors
    • Investor Relations
    • Events & Presentations
    • Stock Quote & Chart
    • Press Releases
    • Corporate Governance
    • SEC Filings
    • Contact
    • Email Alerts
  • Careers
    • Culture
    • Job Openings
  • Contact
    • info@zevra.com
    • 888.958.1253
    • Facebook
    • Twitter
    • LinkedIn
  • Home

© 2026 Zevra Therapeutics, Inc. All rights reserved. Privacy Policy | Terms of Use

Scroll to top